Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Dilworth

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
The Journal of Antimicrobial Chemotherapy|August 28, 2016
Comment on: Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retentionThomas J Dilworth
Journal of Patient-Centered Research and Reviews|October 23, 2024
Determining the Prognostic Value of Complete Blood Count Subgroup Parameters in <i>Staphylococcus aureus</i> BacteremiaEmily L Matthews, Thomas J Dilworth
Infection Control and Hospital Epidemiology|September 28, 2020
Reduction in ambulatory visits for acute, uncomplicated bronchitis: an unintended but welcome result of the coronavirus disease 2019 (COVID-19) pandemicThomas J Dilworth, Charles F Brummitt
Research in Social & Administrative Pharmacy : RSAP|June 16, 2009
Pharmacists' communication with Spanish-speaking patients: a review of the literature to establish an agenda for future researchThomas J Dilworth, , Dave Mott, et al.
Chemotherapy|November 23, 2022
Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli IsolatesHaedi Thelen, Thomas J Dilworth, Renée-Claude Mercier
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 25, 2021
Pragmatic application of AUC-based monitoring recommendations from the 2020 vancomycin consensus guidelinesLucas T Schulz, Thomas J Dilworth, Warren E Rose
Journal of the American Pharmacists Association : Japha|May 11, 2011
Disparities in pharmacists' patient education for Hispanics using antidepressantsHenry N Young, Thomas J Dilworth, David A Mott
Journal of Managed Care & Specialty Pharmacy|December 3, 2014
Impact of an intravenous trimethoprim/sulfamethoxazole shortage on treatment outcomes among HIV-infected patients with Pneumocystis jirovecii pneumoniaThomas J Dilworth, Omar M Ibrahim, Renée-Claude Mercier
Open Forum Infectious Diseases|May 2, 2022
Approaching 65 Years: Is It Time to Consider Retirement of Vancomycin for Treating Methicillin-Resistant <i>Staphylococcus aureus</i> Endovascular Infections?Warren Rose, Cecilia Volk, Thomas J Dilworth, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2014
Reply to "Probability of eradication using vancomycin alone or in combination for methicillin-resistant Staphylococcus aureus bacteremia"Omar M Ibrahim, Thomas J Dilworth, Renée-Claude Mercier
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Antimicrobial Chemotherapy|August 28, 2016
Comment on: Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retentionThomas J Dilworth
Journal of Patient-Centered Research and Reviews|October 23, 2024
Determining the Prognostic Value of Complete Blood Count Subgroup Parameters in <i>Staphylococcus aureus</i> BacteremiaEmily L Matthews, Thomas J Dilworth
Infection Control and Hospital Epidemiology|September 28, 2020
Reduction in ambulatory visits for acute, uncomplicated bronchitis: an unintended but welcome result of the coronavirus disease 2019 (COVID-19) pandemicThomas J Dilworth, Charles F Brummitt
Research in Social & Administrative Pharmacy : RSAP|June 16, 2009
Pharmacists' communication with Spanish-speaking patients: a review of the literature to establish an agenda for future researchThomas J Dilworth, , Dave Mott, et al.
Chemotherapy|November 23, 2022
Examining the Combination of Cefixime and Amoxicillin/Clavulanate against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli IsolatesHaedi Thelen, Thomas J Dilworth, Renée-Claude Mercier
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 25, 2021
Pragmatic application of AUC-based monitoring recommendations from the 2020 vancomycin consensus guidelinesLucas T Schulz, Thomas J Dilworth, Warren E Rose
Journal of the American Pharmacists Association : Japha|May 11, 2011
Disparities in pharmacists' patient education for Hispanics using antidepressantsHenry N Young, Thomas J Dilworth, David A Mott
Journal of Managed Care & Specialty Pharmacy|December 3, 2014
Impact of an intravenous trimethoprim/sulfamethoxazole shortage on treatment outcomes among HIV-infected patients with Pneumocystis jirovecii pneumoniaThomas J Dilworth, Omar M Ibrahim, Renée-Claude Mercier
Open Forum Infectious Diseases|May 2, 2022
Approaching 65 Years: Is It Time to Consider Retirement of Vancomycin for Treating Methicillin-Resistant <i>Staphylococcus aureus</i> Endovascular Infections?Warren Rose, Cecilia Volk, Thomas J Dilworth, et al.
Antimicrobial Agents and Chemotherapy|November 14, 2014
Reply to "Probability of eradication using vancomycin alone or in combination for methicillin-resistant Staphylococcus aureus bacteremia"Omar M Ibrahim, Thomas J Dilworth, Renée-Claude Mercier
Pageof 4